Vaccines

08 Apr 2020 Novavax Identifies Coronavirus Vaccine Candidate; Accelerates Initiation of First-in-Human Trial to Mid-May
08 Apr 2020 EpiVax Partners with GAIA Vaccine Foundation to Make COVID-19 Vaccine License Free to Developing Countries
06 Apr 2020 GSK and Vir Biotechnology enter collaboration to find coronavirus solutions
06 Apr 2020 Akers Biosciences and Premas Biotech Announce Progress in its Vaccine Development for Covid-19
06 Apr 2020 OncoSec Collaborates with Providence Cancer Institute to Conduct First-in-Human Trial of OncoSec's CORVax12, an Investigational Vaccine to Prevent COVID-19, Combining an Enhanced "Spike" DNA Sequence and TAVO™
06 Apr 2020 INOVIO Initiates Phase 1 Clinical Trial Of Its COVID-19 Vaccine and Plans First Dose Today
04 Apr 2020 Update on GSK actions to support the global response to COVID-19
03 Apr 2020 Voltron Therapeutics, Inc. Enters into Sponsored Research Agreement with The Vaccine & Immunotherapy Center at the Massachusetts General Hospital to Develop Potential COVID-19 Vaccine
02 Apr 2020 Applied DNA and Takis Biotech Expand COVID-19 Vaccine Development Program to Include 5th Candidate
01 Apr 2020 Vaxart Provides Update on its Oral COVID-19 Vaccine Program
01 Apr 2020 VBI Vaccines Announces Collaboration with the National Research Council of Canada to Develop Pan-Coronavirus Vaccine Candidate Targeting COVID-19, SARS, and MERS
31 Mar 2020 Cobra Biologics and the Karolinska Institutet collaborate to develop COVID-19 vaccine
30 Mar 2020 Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; Landmark New Partnership with U.S. Department of Health & Human Services; and Commitment to Supply One Billion Vaccines Worldwide for Emergency Pandemic Use
27 Mar 2020 Sanofi Pasteur and Translate Bio to Collaborate to Develop a Novel mRNA Vaccine Candidate Against COVID-19
26 Mar 2020 INOVIO Reports Positive Interim Phase 2 VGX-3100 Results In Patients with HPV-associated Anal Dysplasia
26 Mar 2020 Sorrento Launches Novel I-Cell™ COVID-19 Cellular Vaccine Program
26 Mar 2020 Dynavax and CEPI Announce Collaboration to Support Global Effort to Develop a Vaccine for Coronavirus (COVID-19)
26 Mar 2020 SutroVax Announces $110M Series D Financing to Advance Broadest-Spectrum Pneumococcal Vaccine Candidates to Prevent Pneumonia
25 Mar 2020 Sartorius Supports the Development of the First Vaccine Candidate Against the Novel Coronavirus to Enter Clinical Trials
25 Mar 2020 Akers Biosciences Acquires Licenses to Coronavirus Vaccine Candidate from Premas Biotech
24 Mar 2020 eTheRNA Launches an International Consortium and Starts Development of Cross-strain Protective CoV-2 mRNA Vaccine for High Risk Populations
24 Mar 2020 Ufovax successfully extended its Nanoparticle vaccine technology to SARS-CoV-2
24 Mar 2020 Dynavax and Clover Biopharmaceuticals Announce Research Collaboration to Evaluate Coronavirus (COVID-19) Vaccine Candidate with CpG 1018 Adjuvant
24 Mar 2020 Novavax’ NanoFlu Achieves All Primary Endpoints In Phase 3 Clinical Trial
23 Mar 2020 Hoth Therapeutics Announces Agreement to Joint Development for a Self-Assembling Vaccine (SAV) for the Potential Prevention of the Coronavirus (COVID-19)

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top